(s)-1-chloro-3-[(4-chloro-E-benzylidene)-amino]-propan-2-ol

DRUG INTERMEDIATES

Product Details

CAT No.# CS-CR-00007
Category Drug Intermediates
CAS 1345879-87-9
Molecular Weight 232.11
Molecular Formula C10H11Cl2NO
Synonyms: (2S)-1-chloro-3-[(E)-[(4- chlorophenyl)methylidene]amino]propan-2-ol
Shipping: Free Shipping for worldwide on order above 2000 USD
COA / MSDS:    View COA    MSDS
The balance used are calibrated with weights traceable to National Standards NIST
(s)-1-chloro-3-[(4-chloro-E-benzylidene)-amino]-propan-2-ol Worldwide Suppliers of (s)-1-chloro-3-[(4-chloro-E-benzylidene)-amino]-propan-2-ol Drug Intermediates Clearsynth CS-CR-00007

Product rating: 9 (s)-1-chloro-3-[(4-chloro-E-benzylidene)-amino]-propan-2-ol based on 20 ratings

  1. Drug Intermediates
  2. (s)-1-chloro-3-[(4-chloro-E-benzylidene)-amino]-propan-2-ol
PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. tibolone (848)
11. (Z)-Dimethylvinphos
12. Silodosin Metabolite
13. 2-Phenoxymethanesulfonanilide
14. Nimesulide EP Impurity A
15. Acetone HPLC
16. Nandrolone Decanoate EP impurity F
17. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
18. Thyroxamine
19. Ortho toluene sulfonic acid
20. Sucrose (1623637)




This page contains information about (s)-1-chloro-3-[(4-chloro-E-benzylidene)-amino]-propan-2-ol Cas 1345879-87-9 and its Drug Intermediates.

(s)-1-chloro-3-[(4-chloro-E-benzylidene)-amino]-propan-2-ol (s)-1-chloro-3-[(4-chloro-E-benzylidene)-amino]-propan-2-ol Drug Intermediates of (s)-1-chloro-3-[(4-chloro-E-benzylidene)-amino]-propan-2-ol Drug Intermediates Clearsynth 1345879-87-9 https://www.clearsynth.com/en/temp/CS-CR-00007.jpg

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."